Evaluation of the Sensitivity, Specificity, and Utility of the Reveal® TP (Syphilis) Antibody POCT

NCT05831098 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
600
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

MedMira Laboratories Inc.

Collaborators